CoapTech, Inc. — Form D
CoapTech, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-09. The offering totals $13.5M, of which $7.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-09
- Form: D
- Accession: 0001823195-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.5M
- Amount sold: $7.1M
- Remaining: $6.4M
- Investors: 6
- Date of first sale: 2024-08-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-523479
Issuer
- Name: CoapTech, Inc.
- CIK: 0001823195
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 101 West Dickman Street, BALTIMORE, MD, 21230
- Phone: 443.574.6934
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Peter Boyd | Director | Baltimore, MD |
| Howard Carolan | Director | Baltimore, MD |
| Tim Collins | Director | Baltimore, MD |
| John Osborne | Director | Charleston, SC |
| Daniel Teo | Director | Baltimore, MD |
| Steven Tropello | Director | Baltimore, MD |
| William Walker | Director | NEW YORK, NY |
| Howard Carolan | Executive Officer | Baltimore, MD |
| Steven Tropello | Executive Officer | Baltimore, MD |
| William Niland | Director | Baltimore, MD |
| Timothy Collins | Director | Baltimore, MD |
| Timothy Collins | Executive Officer | Baltimore, MD |
| Jeffrey Katz | Director | Baltimore, MD |
Other filings by this issuer (3)
More